Skip to main content

Year: 2025

Turning Vision Into Value: Cie Portfolio Win as Nativo Is Acquired for $120M

Cie venture studio continues to deliver industry-leading outcomes as Nativo joins Life360’s mission to connect brands with modern families IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Cie, a venture studio, announced today that its portfolio company Nativo, a leading advertising technology provider, has entered into a definitive agreement to be acquired by Life360 (Nasdaq: LIF). The transaction, valued at approximately $120 million in cash and stock, marks another successful outcome of Cie’s venture studio model.Nativo joins a growing list of Cie-built companies that have been acquired such as Cie Games, ASAP Tire, and Titan School Solutions The acquisition advances Life360’s advertising platform by combining family and location insights with Nativo’s premium publisher reach Investors in Nativo include Signia Venture Partners,...

Continue reading

Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 14th, 2025, to discuss the company’s financial results for the third quarter ended September 30, 2025, as well as the company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 164353. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster5.com/Webcast/Page/2306/53250. An audio replay of the call will be available through Friday, November...

Continue reading

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

Q3 2025 net product revenue increased 223% year-over-year to $438 thousand Gross profit/(loss) decreased from $24 thousand to $(100) thousandWASHINGTON, Nov. 13, 2025 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne disease, reported today its financial results for the third fiscal quarter of the 2025 year, ended September 30, 2025. Financial Highlights for the Quarter Ended September 30, 2025:ARAKODA® pharmacy deliveries increased by 14% from 1,319 boxes (Q3 2024) to 1,505 boxes (Q3 2025). The Company posted a gross loss of approximately $100 thousand in the third quarter of 2025, compared to an approximate gross profit of $24 thousand in the third quarter of 2024, due to a one-time inventory write-off associated...

Continue reading

Jeffersonville Bancorp Announces Third Quarter Earnings of $3,293,000 or $0.78 per share and Year to Date Earnings of $9,301,000 or $2.20 per share; Declares Dividend of $0.15

JEFFERSONVILLE, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) — Jeffersonville Bancorp, Inc. (OTCQB – JFBC) announced today third quarter net income of $3,293,000 or $0.78 per share compared to $3,092,000 or $0.73 per share for the same quarter in 2024. The increase in quarterly net income compared to 2024 of $201,000 was primarily attributable to a reduction in interest expense of $554,000 and an increase of $500,000 in loan interest and fees, partially offset by a reduction in other interest and dividend income of $277,000, a reduction in securities interest of $203,000, a gain on sale of foreclosed real estate of $191,000 in 2024, an increase in non-interest expense of $115,000, and an increase in income tax expense of $40,000. Year to date net income as of September 30, 2025 was $9,301,000 or $2.20 per share compared to $8,676,000...

Continue reading

Michael Peralta Joins Future as Chief Revenue Officer

LONDON, Nov. 13, 2025 (GLOBE NEWSWIRE) — Future, the global leader in specialist media, today announced the appointment of Michael Peralta as its new Chief Revenue Officer. Returning to the Group in this key leadership role, Peralta will oversee Future’s global commercial organisation spanning a vast portfolio of specialist media brands comprising B2C and B2B. Peralta, an experienced global media and technology executive, will join the Executive Leadership Team on 3 December 2025, reporting directly to Chief Executive Officer Kevin Li Ying. This strategic appointment comes as Future accelerates its focus on harnessing the power of AI, first-party data, and Retail Media Networks (RMN) to deliver greater value and future-ready solutions for its partners. “Future is investing in the best talent and leadership to supercharge...

Continue reading

Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company

Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree The companies were engaged in a potential environmental services deal for Windtree to acquire Titan Environmental Services, Inc. The executed agreement releases the parties from their reciprocal surviving obligations WARRINGTON, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent with TESI (OTC: TESI), an environmental services company, and Windtree will receive $7.5 million in cash and TESI securities. The companies were engaged on a potential acquisition of Titan Environmental Services, Inc., a waste management...

Continue reading

Goliath Resources Discloses Observations In Holes From This Years Exploration Campaign On The Surebet Discovery, Golden Triangle, B.C.

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Infographics accompanying this announcement are available at  https://www.globenewswire.com/NewsRoom/AttachmentNg/ec2df2de-dfb1-4a07-8407-651fd33a4858 https://www.globenewswire.com/NewsRoom/AttachmentNg/9eb0fcd5-0106-4902-987f-4d7ff49ce32a https://www.globenewswire.com/NewsRoom/AttachmentNg/3aee281a-bd31-48c9-aae4-8122c1e3b6b1 https://www.globenewswire.com/NewsRoom/AttachmentNg/b74c8b60-de44-4c9d-8e1d-27451a40500a100% of the drill holes completed to date on Surebet have intersected substantial quartz-sulphide mineralization. VG-NE was observed in 83 drill holes out of 110 (or 76%) completed in 2025. 92% of the holes (355 out of 386) drilled to date at the Surebet...

Continue reading

Kelyniam Global Secures Exclusive U.S. License for Evonik’s VESTAKEEP® Fusion Biomaterial in Cranial Implants

CANTON, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) — Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from Evonik Industries AG to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material, for cranial, craniofacial, and maxillofacial implants. This agreement grants Kelyniam two years of exclusivity with the option for renewal upon mutual agreement. The license enhances Kelyniam’s regenerative product lineup by incorporating VESTAKEEP® Fusion’s osteoconductive properties, that promote human bone growth and integration. Distributed through Modern Plastics, a trusted long-term supplier of PEEK materials, this partnership leverages a proven relationship to ensure reliable access and supports Kelyniam’s growth...

Continue reading

Hermès International : Shares and voting rights as of 31st October 2025

RELEASE Paris, November 13, 2025 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITALIn accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published.Date Total number of shares Total number of theoretical voting rights (including treasury stock) Total number of effective voting rights (exercisable at shareholders’ meetings) Publications31 October 2025 105 569 412 179 251 764 178 518 628 13 November 202530 September 2025 105 569 412 179 543...

Continue reading

Verkkokauppa.com Oyj: Acquisition of own shares on 13 November 2025

Verkkokauppa.com Oyj, Stock Exchange Release, 13 November 2025 at 07:00 p.m. EET Verkkokauppa.com Oyj: Acquisition of own shares on 13 November 2025Date 13 November 2025  Exchange transaction Buy  Share trading code VERK  Amount, shares 15,306  Average price/share (EUR) 4.0152  Total cost (EUR) 61,456.65  After the acquisitions Verkkokauppa.com Oyj holds a total of  248,736 treasury shares. On behalf of Verkkokauppa.com Oyj Danske Bank A/S, Finland Branch Antti Väliaho                        Jonathan Nyberg For more information, please contact: Jesper Blomster, CFOVerkkokauppa.com Oyjjesper.blomster@verkkokauppa.com Verkkokauppa.com is an e-commerce pioneer that stands passionately on the customer’s side. Verkkokauppa.com accelerates the transition of commerce to online with Finland’s fastest deliveries and ultimate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.